Deferred Income Tax Expense (Benefit) in USD of BIO-TECHNE Corp from 2010 to 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
BIO-TECHNE Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2010 to 2025.
- BIO-TECHNE Corp Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $4.15M, a 5.71% increase year-over-year.
- BIO-TECHNE Corp annual Deferred Income Tax Expense (Benefit) for 2025 was -$51.2M, a 27.4% decline from 2024.
- BIO-TECHNE Corp annual Deferred Income Tax Expense (Benefit) for 2024 was -$40.2M, a 34.8% decline from 2023.
- BIO-TECHNE Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$29.8M, a 522% decline from 2022.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)